Gefitinib Stada

Gefitinib Stada is an oral medication used to treat certain types of cancer. This pharmaceutical is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to therapy.

Gefitinib Stada is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has spread or returned. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Gefitinib used for?' This medication is typically prescribed for advanced stages of NSCLC where the cancer has specific EGFR mutations.

Common effects of Gefitinib Stada may include skin rash, diarrhea, and fatigue. Some users may also experience nausea, loss of appetite, or dry skin. These effects can vary in intensity and duration, depending on individual responses to the medication.

Gefitinib Stada should be handled with care, as it is intended for oral use only. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their doctor about any existing medical conditions or allergies before starting this medication.

Gefitinib Stada may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is advisable to consult a healthcare provider before combining Gefitinib with other medications, especially those known to affect liver function. Additionally, patients should avoid grapefruit and grapefruit juice, as they can interfere with the metabolism of Gefitinib.